Status:
COMPLETED
The Hemodynamic Effects of Vasopressin in Patients With Fontan Physiology
Lead Sponsor:
Stanford University
Conditions:
Hypotension
Fontan Physiology
Eligibility:
All Genders
Phase:
EARLY_PHASE1
Brief Summary
The goal of this study is to evaluate if vasopressin can elevate systemic arterial blood pressures without having a significant effect on pulmonary arterial pressures. Because patients who have underg...
Detailed Description
Patients with Fontan physiology are at increased risk of developing hypotension during periods of illness or with anesthesia. These patients have changes in venous capacitance, compliance, and venomot...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 1\. All patients scheduled for cardiac catheterization at Lucile Packard Children's Hospital with Fontan circulation
- Exclusion criteria:
- Critical illness severe enough to preclude extended cardiac catheterization time
- Patients already on vasopressin
- Patients with pulmonary hypertension.
- Patient not scheduled for cardiac catheterization at Lucile Packard Children's Hospital (LPCH).
Exclusion
Key Trial Info
Start Date :
August 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2022
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04463394
Start Date
August 12 2020
End Date
February 15 2022
Last Update
May 14 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University Medical Center
Stanford, California, United States, 94305
2
Stanford University
Stanford, California, United States, 94305